205 related articles for article (PubMed ID: 8881452)
21. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
[TBL] [Abstract][Full Text] [Related]
22. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
[TBL] [Abstract][Full Text] [Related]
23. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
[TBL] [Abstract][Full Text] [Related]
24. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
26. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma.
Katsama A; Sourvinos G; Zachos G; Spandidos DA
Cancer Lett; 2000 Mar; 150(2):165-70. PubMed ID: 10704738
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
[TBL] [Abstract][Full Text] [Related]
28. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
30. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
31. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma.
Nawroz-Danish HM; Koch WM; Westra WH; Yoo G; Sidransky D
Otolaryngol Head Neck Surg; 1998 Jul; 119(1):21-5. PubMed ID: 9674510
[TBL] [Abstract][Full Text] [Related]
32. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
[TBL] [Abstract][Full Text] [Related]
33. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
[TBL] [Abstract][Full Text] [Related]
34. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
[TBL] [Abstract][Full Text] [Related]
35. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.
Zhu J; Leon SP; Beggs AH; Busque L; Gilliland DG; Black PM
J Clin Endocrinol Metab; 1994 Apr; 78(4):922-7. PubMed ID: 8157722
[TBL] [Abstract][Full Text] [Related]
36. Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues.
Mutirangura A; Charuruks N; Shuangshoti S; Sakdikul S; Chatsantikul R; Pornthanakasem W; Sriuranpong V; Supiyaphun P; Voravud N
Int J Cancer; 1999 Oct; 83(2):210-4. PubMed ID: 10471529
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
[TBL] [Abstract][Full Text] [Related]
38. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
[TBL] [Abstract][Full Text] [Related]
39. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
[TBL] [Abstract][Full Text] [Related]
40. Allelic loss on chromosome 13q in human prostate carcinoma.
Melamed J; Einhorn JM; Ittmann MM
Clin Cancer Res; 1997 Oct; 3(10):1867-72. PubMed ID: 9815575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]